Search results for "Pathway"

showing 10 items of 1685 documents

Cannabinoid receptor 1 and acute resistance exercise – In vivo and in vitro studies in human skeletal muscle

2015

Abstract Aim This study aimed to determine whether Cannabinoid receptor 1 (CB1) is involved in mammalian target of rapamycin (mTOR) signaling and skeletal muscle protein synthesis. Methods This study used human vastus lateralis skeletal muscle biopsies obtained before and after a resistance exercise (RE) bout in young men (n = 18). The signaling mechanisms were studied in vitro in human myotubes. Protein expression was determined by Western blot and confocal microscopy, and gene expression by quantitative PCR. Protein synthesis was measured in vitro using puromycin-based SuNSET technique. Results In human skeletal muscle, an anabolic stimulus in the form of RE down-regulated CB1 expression.…

Malemedicine.medical_specialtyPhysiologyMAP Kinase Signaling SystemMuscle Fibers SkeletalGene ExpressionSkeletal muscleP70-S6 Kinase 1Cell Cycle ProteinsBiochemistryCell LineCellular and Molecular NeuroscienceYoung AdultEndocrinologyPiperidinesReceptor Cannabinoid CB1Internal medicinemedicineCannabinoid receptor type 2HumansCannabinoid receptor 1PhosphorylationMuscle Skeletalta315PI3K/AKT/mTOR pathwayAdaptor Proteins Signal TransducingChemistryMyogenesista1184Eukaryotic initiation factor 4E bindingSkeletal muscleRibosomal Protein S6 Kinases 70-kDaResistance TrainingPhosphoproteinsResistance exerciseCell biologymedicine.anatomical_structureEndocrinologyRibosomal protein s6Protein BiosynthesismTOR signalingPhosphorylationPyrazolesProtein synthesisProtein Processing Post-TranslationalPeptides
researchProduct

Electrophysiological characterization of the pineal gland of golden hamsters.

1987

In one of the most-widely used species in pineal gland research, the strongly photoperiodic golden hamster, Mesocricetus auratus, no electrophysiological data on pinealocytes are currently available. To fill this gap, in the present study 185 spontaneously active pinealocytes from male golden hamsters were recorded extracellularly, both during day- and night-time (light: dark cycle 12 ∶ 12, lights on at 07.00 h). As in other species, pinealocytes exhibited action potentials of 1–2 ms duration. An irregular firing pattern was observed in 95% of the pinealocytes, the remainder fired more regularly or showed a phasic discharge pattern. The firing frequencies ranged from 0.2 to 25 Hz and showed…

Malemedicine.medical_specialtySuperior cervical ganglionHabenular nucleiHamsterAction PotentialsStimulationPineal GlandPinealocytePineal glandInternal medicineCricetinaeNeural PathwaysmedicineAnimalsGanglia SympatheticbiologyMesocricetusChemistryGeneral Neurosciencebiology.organism_classificationElectric StimulationCircadian RhythmEndocrinologymedicine.anatomical_structureOptic ChiasmMesocricetusPhotic StimulationGolden hamsterExperimental brain research
researchProduct

Principal neurons projecting to the pineal gland in close association with small intensely fluorescent cells in the superior cervical ganglion of rats

1988

The localization in the superior cervical ganglia (SCG) of small, intensely fluorescent (SIF) cells and of principal nerve (PN) cells innervating the pineal gland was examined in adult male Sprague-Dawley rats. PN cells were demonstrated by means of the retrograde neuron-tracing method using the fluorescent tracer Fluoro-Gold (FG) injected into the pineal gland. SIF cells were visualized by the formaldehyde-induced fluorescence method. Twenty-nine percent of the FG-labeled PN cells were found closely associated with SIF cells. In the rostral half of the ganglion, 43% of the SIF cells were situated in juxtaposition to one or several labeled neurons. The possible influence of SIF cells on the…

Malemedicine.medical_specialtySuperior cervical ganglionHistologyStilbamidinesCentral nervous systemEnteroendocrine cellBiologyPineal GlandPathology and Forensic MedicinePineal glandFormaldehydeInternal medicineNeural PathwaysmedicineAnimalsFluorescent DyesNeuronsGanglia SympatheticRats Inbred StrainsCell BiologyRetrograde tracingMolecular biologyRatsGanglionmedicine.anatomical_structureEndocrinologyMicroscopy Fluorescencenervous systemCervical gangliaNeuronCell and Tissue Research
researchProduct

Bradykinin Contracts Rat Urinary Bladder Largely Independently of Phospholipase C

2014

Several receptor systems in the bladder causing detrusor smooth muscle contraction stimulate phospholipase C (PLC). PLC inhibition abolishes bladder contraction via P2Y6 but not that via M3 muscarinic receptors, indicating a receptor-dependent role of PLC. Therefore, we explored the role of PLC in rat bladder contraction by bradykinin. The PLC inhibitor U 73,122 [1-(6-[([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)-amino]hexyl)-1H-pyrrole-2,5-dione] did not affect the bradykinin response to a significantly greater degree than its inactive analog U 73,343 [10 μM each; 1-(6-[-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)-amino]hexyl)-2,5-pyrrolidinedione], whereas the phospholipase D inhibitor b…

Malemedicine.medical_specialtyUrinary BladderMedizinBradykininPharmacologyBradykininCyclooxygenase pathwaychemistry.chemical_compoundOrgan Culture TechniquesInternal medicinemedicineAnimalsCalphostinRats WistarBradykinin receptorPharmacologyDose-Response Relationship DrugPhospholipase CMuscle SmoothSmooth muscle contractionRatsChelerythrineEndocrinologychemistryRho kinase inhibitorType C PhospholipasesMolecular MedicineMuscle ContractionJournal of Pharmacology and Experimental Therapeutics
researchProduct

A cervical myelopathy with a Hirayama disease-like phenotype

2008

A 21-year-old man with a muscular atrophy of the left distal upper extremity is presented. The disorder had been progressive over a few years, showing an exacerbation of the hand's weakness when the patient worked in a chilled environment (i.e., in a cold room). The patient's diagnostic work-up was extensive and the MRI documented the presence of a cervical myelopathy, associated to an inversion of the physiological lordosis at the C5-C6 level, with a phenotype highly resembling Hirayama disease. This case indirectly supports the debated hypothesis that juvenile amyotrophy of the upper limb (Hirayama disease) is actually a type of cervical myelopathy, with a likely ischaemic pathogenesis of…

Malemedicine.medical_specialtyWeaknessHIRAYAMANeurologyCumulative Trauma DisordersDermatologyFunctional LateralityMuscular Atrophy SpinalYoung AdultMyelopathyAtrophyIschemiaSpinal cord compressionNeural PathwaysmedicineHumansKyphosisMuscle SkeletalCervical myelopathy Hirayama disease Muscular atrophy MRIMuscle Weaknessbusiness.industryMuscle weaknessSyndromeGeneral MedicineAnatomyAmyotrophymedicine.diseaseMagnetic Resonance ImagingCold TemperatureOccupational DiseasesPsychiatry and Mental healthmedicine.anatomical_structureSpinal CordArmCervical VertebraeDisease ProgressionUpper limbSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusinessSpinal Cord CompressionNeurological Sciences
researchProduct

Retinal nerve fibre layer and brain grey substance as early prognostic factors for disability in multiple sclerosis.

2012

We read with interest the article by Bock et al ,1 in which the association between retinal nerve fibre layer (RNFL) and total macular volume (TMV) was analysed by optical coherence tomography (OCT) and contrast sensitivity was measured by functional acuity contrast testing in relapsing-remitting multiple sclerosis (MS) patients. The authors found that the functional contrast vision in MS is influenced by morphological changes in the anterior visual pathway. This work emphasised that contrast sensitivity is reduced in MS, and that RNFL and TMV, as morphological measures of retinal axon loss, are predictors of contrast sensitivity. Ophthalmological examinations were the basis of the Bock et …

Malemedicine.medical_specialtygenetic structuresAnterior Visual Pathwaymedia_common.quotation_subjectVision DisordersVisual AcuityNerve fibre layerGrey substanceContrast SensitivityCellular and Molecular Neurosciencechemistry.chemical_compoundMultiple Sclerosis Relapsing-RemittingOptical coherence tomographyOphthalmologymedicineContrast (vision)HumansMacula Luteamedia_commonmedicine.diagnostic_testbusiness.industryMultiple sclerosisRetinalAnatomymedicine.diseaseeye diseasesSensory SystemsAxon lossOphthalmologychemistryFemalesense organsbusinessThe British journal of ophthalmology
researchProduct

Delayed neonatal visual evoked potentials are associated to asymmetric growth pattern in twins

2020

Abstract Objectives To study the association between intrauterine growth and visual pathways maturation by neonatal visual evoked potentials (VEPs) in twins, in view of a possible prognostic role. Methods Seventy-four twin neonates from 37 pregnancies were selected based on gestational age of more than 30 weeks and uneventful perinatal clinical course. Flash VEPs were recorded at the same postmenstrual age in each twin pair. The association between P2 latency and anthropometric variables at birth was analyzed by comparison within each twin pair and regarding each variable as ordered difference between the two twins. Results Analysis of differences within each twin pair highlighted that inte…

Malemedicine.medical_specialtygenetic structuresTwinsSocio-culturaleVisual system050105 experimental psychologyFetal DevelopmentCorrelation03 medical and health sciencesChild Development0302 clinical medicinePhysiology (medical)Internal medicinemedicineHumansVisual Pathways0501 psychology and cognitive sciencesLatency (engineering)Visual evoked potential latencyPonderal IndexBody mass indexVisual Cortexbusiness.industry05 social sciencesInfant NewbornPostmenstrual AgeTwinGestational ageElectroencephalographyIntrauterine growthAnthropometryAsymmetric growthBody mass index; Intrauterine growth; Ponderal Index; Twins; Visual evoked potential latencySensory SystemsNeurologyCardiologyEvoked Potentials VisualFemaleNeurology (clinical)businessBody mass index030217 neurology & neurosurgeryClinical Neurophysiology
researchProduct

Effect of sertraline treatment on benzodiazepine receptors in the rat brain.

1993

In this paper we describe the modification of benzodiazepine (BDZ) binding sites in the rat brain after different times of treatment with the 5-hydroxytryptamine-(5HT) uptake blocker sertraline. We investigated the effect of 8, 15 and 30 days sertraline treatment (10 mg/kg/day, i.p.) on 3 H-flunitrazepam binding sites. In order to describe the anatomical site of action of the drug, the experiment has been carried out by means of quantitative receptor autoradiography. After 8 days of sertraline treatment, an increase of BDZ receptor density is found in the olfactory tubercle. This effect is reversed at 15 and 30 days. At 15 days of treatment, an increase is found in the anterior cingulate co…

Malemedicine.medical_specialtymedicine.drug_classRats Sprague-DawleyInternal medicineSertralinemedicineLimbic SystemAnimalsReceptorBiological Psychiatry5-HT receptorBrain ChemistryCerebral CortexBenzodiazepineSertralineBehavior AnimalGABAA receptorChemistryOlfactory tubercleBody WeightSeptal nucleiOlfactory PathwaysReceptors GABA-AAntidepressive AgentsRatsPsychiatry and Mental healthmedicine.anatomical_structureEndocrinology1-NaphthylamineNeurologyAnti-Anxiety AgentsCerebral cortexNeurology (clinical)Selective Serotonin Reuptake Inhibitorsmedicine.drugJournal of neural transmission. General section
researchProduct

A case study of Primary Progressive Aphasia: improvement on verbs after rTMS treatment.

2006

This case-report shows that high frequency repetitive Transcranial Magnetic Stimulation (hf-rTMS), applied to the left prefrontal cortex, may improve the linguistic skills in Primary Progressive Aphasia (PPA). The patient's performance was evaluated on a battery of language production and memory span tasks, before and after two hf-rTMS treatments and one SHAM treatment. We observed a significant and lasting improvement of the patient's performance on verb production following the application of hf-rTMS versus Baseline and SHAM conditions. This finding suggests that hf-rTMS may directly strengthen the neural connections within an area of metabolic dysfunction and encourages the use of rTMS a…

Malemedicine.medical_specialtymedicine.medical_treatmentPrefrontal CortexVerbbehavioral disciplines and activitiesSettore BIO/09 - FisiologiaPrimary progressive aphasiaPhysical medicine and rehabilitationElectromagnetic FieldsArts and Humanities (miscellaneous)MemoryAphasiarTMSNeural PathwaysmedicineMemory spanHumansLanguageMemory DisordersLanguage TestsLanguage productionSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaVerbal BehaviorLinguistic skillsMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTranscranial Magnetic StimulationPrimary Progressive AphasiaTranscranial magnetic stimulationAphasia Primary ProgressiveTreatment Outcomenervous systemLeft prefrontal cortexSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomAtrophyPsychologyPPANeurosciencepsychological phenomena and processesNeurocase
researchProduct

Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX

2019

Objectives: FXIa (factor XIa) induces clot formation, and human congenital FXI deficiency protects against venous thromboembolism and stroke. In contrast, the role of FXI in hemostasis is rather small, especially compared with FIX deficiency. Little is known about the cause of the difference in phenotypes associated with FIX deficiency and FXI deficiency. We speculated that activation of FIX via the intrinsic coagulation is not solely dependent on FXI(a; activated FXI) and aimed at identifying an FXI-independent FIX activation pathway. Approach and Results: We observed that ellagic acid and long-chain polyphosphates activated the coagulation system in FXI-deficient plasma, as could be demo…

Malemedicine.medical_specialtyplasma kallikreinPREKALLIKREIN030204 cardiovascular system & hematologyPATHWAYMice03 medical and health sciencesTissue factor0302 clinical medicineThrombinInternal medicinemedicineAnimalsHEMOSTASIScoagulationBLOOD-COAGULATIONBlood CoagulationFactor XIFactor IXfactor IXPURIFICATIONbusiness.industryMOLECULAR-WEIGHT KININOGENThrombinPrekallikreinKallikreinfactor XIfactor XI deficiencyMice Inbred C57BLDEFICIENCYDisease Models AnimalTHROMBOSISEndocrinologyCoagulationTISSUE FACTOR030220 oncology & carcinogenesisHemostasisFemaleREDUCED INCIDENCECardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct